PortfoliosLab logoPortfoliosLab logo
IRMD vs. INTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IRMD vs. INTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IRadimed Corporation (IRMD) and Intuit Inc. (INTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IRMD achieves a -7.24% return, which is significantly higher than INTU's -51.13% return. Over the past 10 years, IRMD has outperformed INTU with an annualized return of 17.93%, while INTU has yielded a comparatively lower 12.47% annualized return.


IRMD

1D
-2.38%
1M
3.35%
YTD
-7.24%
6M
-1.47%
1Y
57.66%
3Y*
24.41%
5Y*
28.64%
10Y*
17.93%

INTU

1D
-8.94%
1M
-19.27%
YTD
-51.13%
6M
-49.07%
1Y
-57.55%
3Y*
-8.58%
5Y*
-5.87%
10Y*
12.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IRMD vs. INTU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IRMD
IRadimed Corporation
-7.24%79.69%16.99%75.37%-37.53%102.68%-2.48%-4.42%61.45%36.49%
INTU
Intuit Inc.
-51.13%6.09%1.16%61.76%-39.12%70.27%46.12%34.11%25.86%39.21%

Correlation

The correlation between IRMD and INTU is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jul 17, 2014

0.20

The correlation between IRMD and INTU shifts across timeframes, from 0.07 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IRMD:

$1.16B

INTU:

$88.91B

EPS

IRMD:

$1.84

INTU:

$16.37

PE Ratio

IRMD:

48.94

INTU:

19.68

PEG Ratio

IRMD:

2.04

INTU:

1.18

PS Ratio

IRMD:

13.39

INTU:

4.31

PB Ratio

IRMD:

11.74

INTU:

4.31

Total Revenue (TTM)

IRMD:

$86.28M

INTU:

$20.93B

Gross Profit (TTM)

IRMD:

$66.30M

INTU:

$16.97B

EBITDA (TTM)

IRMD:

$30.55M

INTU:

$6.65B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IRMD vs. INTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IRMD
IRMD Risk / Return Rank: 8282
Overall Rank
IRMD Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
IRMD Sortino Ratio Rank: 8383
Sortino Ratio Rank
IRMD Omega Ratio Rank: 8181
Omega Ratio Rank
IRMD Calmar Ratio Rank: 8080
Calmar Ratio Rank
IRMD Martin Ratio Rank: 8383
Martin Ratio Rank

INTU
INTU Risk / Return Rank: 22
Overall Rank
INTU Sharpe Ratio Rank: 11
Sharpe Ratio Rank
INTU Sortino Ratio Rank: 22
Sortino Ratio Rank
INTU Omega Ratio Rank: 22
Omega Ratio Rank
INTU Calmar Ratio Rank: 55
Calmar Ratio Rank
INTU Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IRMD vs. INTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Intuit Inc. (INTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IRMDINTUDifference

Sharpe ratio

Return per unit of total volatility

1.72

-1.32

+3.03

Sortino ratio

Return per unit of downside risk

2.63

-2.06

+4.68

Omega ratio

Gain probability vs. loss probability

1.32

0.72

+0.60

Calmar ratio

Return relative to maximum drawdown

2.79

-0.92

+3.70

Martin ratio

Return relative to average drawdown

8.18

-1.78

+9.96

IRMD vs. INTU - Sharpe Ratio Comparison

The current IRMD Sharpe Ratio is 1.72, which is higher than the INTU Sharpe Ratio of -1.32. The chart below compares the historical Sharpe Ratios of IRMD and INTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IRMDINTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.72

-1.32

+3.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.66

-0.16

+0.82

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.37

0.37

0.00

Sharpe Ratio (All Time)

Calculated using the full available price history

0.42

0.36

+0.07

Drawdowns

IRMD vs. INTU - Drawdown Comparison

The maximum IRMD drawdown since its inception was -75.83%, roughly equal to the maximum INTU drawdown of -75.29%. Use the drawdown chart below to compare losses from any high point for IRMD and INTU.


Loading charts...

Drawdown Indicators


IRMDINTUDifference

Max Drawdown

Largest peak-to-trough decline

-75.83%

-75.29%

-0.54%

Max Drawdown (1Y)

Largest decline over 1 year

-20.62%

-62.05%

+41.43%

Max Drawdown (3Y)

Largest decline over 3 years

-26.28%

-62.05%

+35.77%

Max Drawdown (5Y)

Largest decline over 5 years

-49.38%

-62.05%

+12.67%

Max Drawdown (10Y)

Largest decline over 10 years

-64.30%

-62.05%

-2.25%

Current Drawdown

Current decline from peak

-14.31%

-59.83%

+45.52%

Average Drawdown

Average peak-to-trough decline

-28.09%

-24.11%

-3.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.02%

31.98%

-24.96%

Volatility

IRMD vs. INTU - Volatility Comparison

The current volatility for IRadimed Corporation (IRMD) is 7.97%, while Intuit Inc. (INTU) has a volatility of 28.80%. This indicates that IRMD experiences smaller price fluctuations and is considered to be less risky than INTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IRMDINTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.97%

28.80%

-20.83%

Volatility (6M)

Calculated over the trailing 6-month period

21.34%

42.26%

-20.92%

Volatility (1Y)

Calculated over the trailing 1-year period

33.78%

43.84%

-10.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.56%

37.42%

+6.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.58%

33.90%

+14.68%

Dividends

IRMD vs. INTU - Dividend Comparison

IRMD's dividend yield for the trailing twelve months is around 1.38%, less than INTU's 1.44% yield.


PositionTTM20252024202320222021202020192018201720162015
INTU
Intuit Inc.
1.44%0.65%0.60%0.52%0.72%0.38%0.57%0.74%0.83%0.89%1.08%1.09%
IRMD
IRadimed Corporation
1.38%1.21%0.82%3.54%3.53%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

IRMD vs. INTU - Financials Comparison

This section allows you to compare key financial metrics between IRadimed Corporation and Intuit Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
21.98M
8.56B
(IRMD) Total Revenue
(INTU) Total Revenue
Values in USD except per share items

IRMD vs. INTU - Profitability Comparison

The chart below illustrates the profitability comparison between IRadimed Corporation and Intuit Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

74.0%76.0%78.0%80.0%82.0%84.0%86.0%20222023202420252026
76.5%
84.6%
Portfolio components
IRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported a gross profit of 16.81M and revenue of 21.98M. Therefore, the gross margin over that period was 76.5%.

INTU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intuit Inc. reported a gross profit of 7.24B and revenue of 8.56B. Therefore, the gross margin over that period was 84.6%.

IRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported an operating income of 7.24M and revenue of 21.98M, resulting in an operating margin of 32.9%.

INTU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intuit Inc. reported an operating income of 4.02B and revenue of 8.56B, resulting in an operating margin of 47.0%.

IRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IRadimed Corporation reported a net income of 5.82M and revenue of 21.98M, resulting in a net margin of 26.5%.

INTU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intuit Inc. reported a net income of 3.06B and revenue of 8.56B, resulting in a net margin of 35.8%.


Frequently Asked Questions


IRMD and INTU have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INTU has higher volatility (28.80%) compared to IRMD (7.97%). In terms of maximum drawdown, IRMD dropped -75.83% vs INTU's -75.29%.

IRMD currently has the higher Sharpe Ratio (1.72 vs -1.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IRMD and INTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer